#582: GLP-1 Agonists: Side Effects, Management and Diet – Dr. Spencer Nadolsky

#582: GLP-1 Agonists: Side Effects, Management and Diet – Dr. Spencer Nadolsky

Author: Danny Lennon October 28, 2025 Duration: 48:30

GLP-1 receptor agonists have emerged as a groundbreaking tool in obesity treatment. In this episode, Dr. Spencer Nadolsky (an obesity specialist) explains how these medications are now yielding unprecedented weight loss outcomes in people with obesity. 

The discussion centers on GLP-1 agonist drugs like semaglutide and tirzepatide: how they work, how much weight loss they can produce, and why they represent a paradigm shift in obesity management. 

Importantly, the conversation addresses practical aspects of using these drugs, including managing their side effects and optimizing patients' diet and lifestyle while on therapy.

This topic is of great significance to nutrition science, clinical practice, and public health. Obesity is a chronic, relapsing condition that has proven difficult to treat with lifestyle changes alone. The advent of GLP-1 agonists offers new hope by inducing weight loss levels previously seen only with surgical interventions. 

Understanding these medications is crucial for healthcare professionals: it enables evidence-based prescribing, proper patient counseling on diet and side effects, and integration of medication with lifestyle interventions. 

Discussing safety and long-term use is vital, as millions more patients might use these drugs in coming years. From a public health perspective, GLP-1 agonists prompt debates about access and cost, given their high price and life-changing potential.

Timestamps

  • [03:25] Conversation with Dr. Spencer Nadolsky begins
  • [05:24] Mechanism and types of GLP-1 medications
  • [07:55] Efficacy and weight loss results
  • [16:53] Common side effects and management
  • [22:57] Muscle loss concerns and clinical insights
  • [28:09] Addressing nutritional concerns with GLP-1 medications
  • [29:38] Exploring potential benefits beyond weight loss
  • [33:48] Marketing and misconceptions around GLP-1
  • [36:59] Public health and accessibility issues
  • [43:25] Future research
  • [46:16] Key ideas segment (Premium-only)

Related Resources


Sigma Nutrition Radio, hosted by nutrition scientist Danny Lennon, moves beyond the noise of diet trends and simplistic advice to explore the complex, fascinating world of human nutrition. This is a space for deep, evidence-based conversations that acknowledge the nuance and often contradictory nature of scientific research. Each episode delves into a specific topic within health, fitness, or dietetics, breaking down the underlying physiology, examining the latest studies, and discussing practical implications with expert guests. The goal isn't to hand out rigid meal plans but to cultivate the critical thinking skills necessary to navigate the ever-changing landscape of nutritional science. You'll hear detailed analyses of how research is conducted, thoughtful debates on contentious issues, and explorations of how evidence translates-or doesn't-into real-world recommendations for different individuals. Tuning into this podcast means committing to a more sophisticated understanding of how food, movement, and metabolism interact, leaving you better equipped to make informed decisions about your own health and skepticism towards the next big headline. Danny’s approach is both rigorous and accessible, making even the most detailed biochemical pathways relevant to everyday life. It’s for anyone who has ever wondered about the real story behind a nutrition claim and values substance over soundbites.
Author: Language: English Episodes: 100

Sigma Nutrition Radio
Podcast Episodes
#600: Finite Knowledge, Infinite Ignorance [not-audio_url] [/not-audio_url]

Duration: 2:00:12
"The more we learn about the world, and the deeper our learning, the more conscious, specific, and articulate will be our knowledge of what we do not know, our knowledge of our ignorance. For this, indeed, is the main so…
#596: Why Do Omega-3 Trials Show Mixed Results? [not-audio_url] [/not-audio_url]

Duration: 1:06:11
Omega-3 fatty acids (particularly EPA and DHA) have a long history in nutrition and cardiovascular medicine, yet the clinical trial literature is often perceived as inconsistent. This episode examines why some randomized…
How Much Dietary Fiber Do We Need to be Healthy? (SNP48) [not-audio_url] [/not-audio_url]

Duration: 20:45
This is a Premium-exclusive episode of the podcast. To listen to the full episode you need to be subscribed to Sigma Nutrition Premium. This episode examines dietary fiber through the lens of a practical, clinically rele…